The multinational Merck/Schering Plough launched Simvastatin (sim-va-stat-in) back in the January of 2008 to treat cholesterol related cardiac problems either singularly or in association with Ezetimibe and the brand name for the drug was Zocor® It is believed to lower the ‘bad’ cholesterols and triglycerides